60 related articles for article (PubMed ID: 34257581)
1. Detection of EGFR mutation in supernatant, cell pellets of pleural effusion and tumor tissues from non-small cell lung cancer patients by high resolution melting analysis and sequencing.
Lin J; Gu Y; Du R; Deng M; Lu Y; Ding Y
Int J Clin Exp Pathol; 2014; 7(12):8813-22. PubMed ID: 25674250
[TBL] [Abstract][Full Text] [Related]
2. Pleural effusion supernatant: a reliable resource for cell-free DNA in molecular testing of lung cancer.
Thakur S; Rathor A; Jain S; Nambirajan A; Khurana S; Malik PS; Jain D
J Am Soc Cytopathol; 2024 Mar; ():. PubMed ID: 38704351
[TBL] [Abstract][Full Text] [Related]
3. Impact of Simultaneous Circulating Tumor DNA and Tissue Genotyping in the Workup of Stage IV Lung Adenocarcinoma on Quality of Care in an Academic Community Medical Center.
Maity AP; Gangireddy M; Degen KC; Al-Saleem FH; Bramson J; Ciocca V; Dessain SK; Evans TL
JCO Oncol Pract; 2023 Aug; 19(8):620-625. PubMed ID: 37319386
[TBL] [Abstract][Full Text] [Related]
4. Clinical application of the Lung Cancer Compact Panel
Kunimasa K; Tamiya M; Inoue T; Kawamura T; Miyazaki A; Kojitani Y; Honma K; Nishino K
Lung Cancer; 2024 Mar; 189():107498. PubMed ID: 38324922
[TBL] [Abstract][Full Text] [Related]
5. A fast, affordable and minimally-invasive diagnostic test for Cancer of Unknown Primary (CUP) using DNA methylation profiling.
De Wilde J; Van Paemel R; De Koker A; Roelandt S; Van de Velde S; Callewaert N; Van Dorpe J; Creytens D; De Wilde B; De Preter K
Lab Invest; 2024 Jun; ():102091. PubMed ID: 38830578
[TBL] [Abstract][Full Text] [Related]
6. Cell Painting predicts impact of lung cancer variants.
Caicedo JC; Arevalo J; Piccioni F; Bray MA; Hartland CL; Wu X; Brooks AN; Berger AH; Boehm JS; Carpenter AE; Singh S
Mol Biol Cell; 2022 May; 33(6):ar49. PubMed ID: 35353015
[TBL] [Abstract][Full Text] [Related]
7. High Yield of Pleural Cell-Free DNA for Diagnosis of Oncogenic Mutations in Lung Adenocarcinoma.
Mahmood K; Jampani P; Clarke JM; Wolf S; Wang X; Wahidi MM; Giovacchini CX; Dorry M; Shofer SL; Shier J; Jones G; Antonia SJ; Nixon AB
Chest; 2023 Jul; 164(1):252-261. PubMed ID: 36693563
[TBL] [Abstract][Full Text] [Related]
8. Transcending Blood-Opportunities for Alternate Liquid Biopsies in Oncology.
Werner B; Warton K; Ford CE
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267615
[TBL] [Abstract][Full Text] [Related]
9. Distinct profile of cell-free DNA in malignant pleural effusion of non-small cell lung cancer and its impact on clinical genetic testing.
Yu Y; Qian J; Shen L; Ji W; Lu S
Int J Med Sci; 2021; 18(6):1510-1518. PubMed ID: 33628109
[TBL] [Abstract][Full Text] [Related]
10. Malignant pleural effusions for cancer genotyping: A matter of trans-pleural traffic of cell-free tumor DNA.
Méhes G; Mokánszki A; Tóth L; Csoma SL; Lieber A; Bittner N
Mol Cell Probes; 2022 Feb; 61():101793. PubMed ID: 35114325
[TBL] [Abstract][Full Text] [Related]
11. Liquid biopsy approaches for pleural effusion in lung cancer patients.
Baburaj G; Damerla RR; Udupa KS; Parida P; Munisamy M; Kolesar J; Rao M
Mol Biol Rep; 2020 Oct; 47(10):8179-8187. PubMed ID: 33029702
[TBL] [Abstract][Full Text] [Related]
12. Cell-free DNA From Pleural Effusion Samples: Is It Right for Molecular Testing in Lung Adenocarcinoma?
Mokánszki A; Bádon ES; Mónus A; Tóth L; Bittner N; Méhes G
Pathol Oncol Res; 2021; 27():613071. PubMed ID: 34257581
[TBL] [Abstract][Full Text] [Related]
13. Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: a comparison between cell-free DNA and extracellular vesicle-derived DNA.
Lee JS; Hur JY; Kim IA; Kim HJ; Choi CM; Lee JC; Kim WS; Lee KY
BMC Cancer; 2018 Dec; 18(1):1236. PubMed ID: 30526536
[TBL] [Abstract][Full Text] [Related]
14. Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancer.
Tong L; Ding N; Tong X; Li J; Zhang Y; Wang X; Xu X; Ye M; Li C; Wu X; Bao H; Zhang X; Hong Q; Song Y; Shao YW; Bai C; Zhou J; Hu J
Theranostics; 2019; 9(19):5532-5541. PubMed ID: 31534501
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
